肝门胆管癌外科治疗体会:附36例报告
作者:
通讯作者:
作者单位:

作者简介:

杨凤辉

基金项目:


Surgical treatment of hilar cholangiocarcinoma:a report of 36 cases
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 音频文件
  • |
  • 视频文件
    摘要:

    目的:探讨肝门部胆管癌的外科治疗及疗效。方法:对近5年间手术治疗的肝门胆管癌36例的临床资料进行回顾性分析和总结。结果:全组均行手术治疗,发生手术后并发症8例,其中胆瘘5例,腹腔内感染2例,上消化道出血1例,均保守治疗而愈,无手术死亡。在行肿瘤切除术的20例中,15例获随访,存活最短时间为11个月,最长时间3年2个月,中位生存时间1年9个月,1年生存率86.7%(13/15), 3年生存率13.3%(2/15)。其他各种内外引流术式16例,术后生存5~12个月,平均10个月,术后短期内黄疸减轻,生活质量提高。 结论:肝门部胆管癌应积极手术,不能切除者应力争行各种引流术。

    Abstract:

    Abstract:Objective:To discuss the diagnosis and surgical treatment of hilar cholangiocarcinoma(HCC). Methods:The clinical data of 36 cases of HCC undergoing surgical treatment in the recent 5 years were analysed and summarized retrospectivly. Results:All of the patients in this group underwent operation. Postoperative complications occurred in 8 patients, included biliary fistula in 5, intra-abdominal infection in 2 and upper gastrointestinal bleeding in 1; all of the patients recovered with conservative treatment. There was no operative mortality.Of 20 patients who had received tumor resection , 15 were followed up.The median survival time was 1 year and 9 months, and the 1- and 3-year survival rate was 86.7%(13/15) and 13.3%(2/15) respectively. The shortest survival time was 11 months and the longest survuval time was 3 years and 2 month.Survival time was from 5 to 12 months and jaundice was relieved and life quality was improved in 16 and patients who received internal or external drainage. Conclusions:HCC should be resected energetically,and,whenever possible,internal or external drainage should be done in unresectable patients.

    参考文献
    相似文献
    引证文献
引用本文

杨凤辉,高德宗,王占民.肝门胆管癌外科治疗体会:附36例报告[J].中国普通外科杂志,2005,14(1):14-.
DOI:10.7659/j. issn.1005-6947.2005.01.014

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2005-01-25